baber/WOPTO huggingface dataset:
Patent IL-93494-A0 (IL)
Title: Acoustic impact delivery catheter with end cap
IPC: A61B17/92
Filed: 1990-02-22
Abstract: Method and apparatus for fracturing hard deposits (20, 110, 122) such as urinary and biliary stones and atherosclerotic plaque in the human body. A flexible guide (10, 40, 60, 84, 100) having a hard mass (12, 42, 64, 86, 104, 120) capping an end is adapted for insertion through a fluid passage in a living body. An energy source (22, 52, 74, 80) creates a rapid vapor expansion adjacent to the cap (12, 42, 64, 86, 104, 120) causing it to undergo a pulse like movement, imparting a high-velocity impulse to an adjacent deposit (30, 110, 122), thereby fracturing it. The energy source (22, 52, 74, 80) may be a laser (22) with a fiber optic (14) delivery system in the guide (10) terminating adjacent to the cap (12) to cause vaporization of the mass cap (12) to create the vapor expansion. The energy source (22, 52, 74, 80) may be a spark generator (52, 74, 80) with a conductor (46, 66, 82) associated with the guide (40, 60, 84, 100) to deliver a fluid vaporizing spark (126) adjacent to the mass cap (42, 64, 86, 104, 120). Other forms of rapid energy delivery such as chemical detonations or ballistic impact may also be applicable.
Patent AU-PM349094-A0 (AU)
Title: Surface treatment of substrates
IPC: C08J7/12
Filed: 1994-01-25
Abstract: PCT No. PCT/AU95/00034 Sec. 371 Date Jul. 19, 1996 Sec. 102(e) Date Jul. 19, 1996 PCT Filed Jan. 24, 1995 PCT Pub. No. WO95/19995 PCT Pub. Date Jul. 27, 1995A method of increasing the adhesion of a rubber (as hereinbefore defined) or rubber-based material which includes treating at least part of the surface of the rubber or rubber-based material with a halogenating agent simultaneously with a static and/or high freguency alternating physical field.
Patent AU-PQ450999-A0 (AU)
Title: Storage and dispensing of carbonated beverages
IPC: B67D1/00
Filed: 1999-12-07
Abstract: A cap to close off an externally threaded aperture of a container is provided. The cap includes a base wall and a peripheral skirt carrying an internal thread for mating with the aperture's external thread. A hollow spigot portion extends from the base wall within the cap, and is co-axial with the skirt and attached to the base wall by a frangible connection. Grooves or thread are formed on the outside wall of the spigot portion to engage the wall of the bore in the aperture. A method of sealing a container including engaging a cap is also provided.
Patent IL-106807-A0 (IL)
Title: An incinerator system
IPC: F23G5/16
Filed: 1993-08-26
Abstract: An incinerator system for bulk refuse and hydrocarbon-containing liquids comprises an enclosed main chamber (32) having a fire-resistant floor means (33) for holding and burning material thereon; an inlet opening (231) for the introduction of solid bulk refuse; an outlet opening (67,68) for the egress of the gaseous products of combustion from said main chamber; a grate (436) located within said main chamber for holding refuse newly introduced through said inlet opening (231); and cooling means for reducing the temperature of said grate. The cooling means comprises primary passageways for receiving a flow of cooling fluid and nozzles for providing fluid communication between said passageways and said main chamber (32). The cooling means further comprises a further passageway isolated from said main chamber (32) so that cooling fluid flowing in said further passageway is prevented from entering said main chamber. Control means is provided for selectively permitting cooling fluid to flow through said primary passageways and then through said further passageway. <IMAGE>
Patent IL-107401-A0 (IL)
Title: Reciprocating engine
IPC: F03C99/00
Filed: 1993-10-25
Abstract: PCT No. PCT/AU93/00547 Sec. 371 Date Apr. 21, 1995 Sec. 102(e) Date Apr. 21, 1995 PCT Filed Oct. 22, 1993 PCT Pub. No. WO94/10452 PCT Pub. Date May 11, 1994An engine for driving a piston arrangement for pumping water from an inlet to an outlet at a higher level is disclosed. The engine includes a hollow housing having an inlet and an outlet between which liquid passes, the housing at least partly enclosing a chamber through which the liquid flows from the inlet to the outlet. A movable wall is mounted in the housing and partly defines the chamber. A valve is provided to open and close the outlet so that when it closes, liquid in the chamber is suddenly decelerated producing an increase in pressure in the chamber to force the wall to move to a direction so as to increase the volume of the chamber. After an initial increase in the pressure, the water relaxes and the pressure decreases to such an extent that a spring will open the valve and the spring returns the wall to the position of decreased volume in the chamber. Thus, the wall is caused to reciprocate under the influence of pressure of the liquid increasing and decreasing as the valve is opened and shut.
Patent IL-125013-A0 (IL)
Title: Liquid crystalline displays with a retardation layer
IPC: G02F1/13363
Filed: 1996-12-16
Abstract: The invention is directed to a liquid crystalline display comprising a display cell containing liquid crystalline material and a retardation layer. The retardation layer comprises a, preferably slightly cross-linked, high-molecular weight material layer and a substrate, wherein the high-molecular weight material has a nematic phase above its Tg and a dynamic viscosity at the working temperature of at least 100 Pa.s. The difference of the Tc of the high-molecular weight material and the Tc of the low-molecular weight material of the display cell (TCcell) is in the range of -30 DEG  C. to +30 DEG  C., preferably in the range of -20 DEG  C. to +20 DEG  C., and more preferably in the range of -10 DEG  C. to +10 DEG  C.; and the Tg of the high-molecular weight liquid crystalline material is lower than 50 DEG  C. It was found that if high-molecular weight material is used with a Tc comparable with that of the, preferably low-molecular weight, liquid crystalline material of the active cell, the temperature dependency of the retardation value of the retardation layer is comparable with that of the active cell. Thus, the retardation value of the retardation layer is comparable with that of the active cell within the temperature range in which displays are used. It was further found that by cross-linking of the high molecular weight liquid crystalline material, the retardation layers according to the invention become less susceptible to pinhole forming and unwanted variation of the twist, and have improved mechanical stability.
Patent IL-127378-A0 (IL)
Title: Enteric coating for an oral preparation
IPC: A61K9/36
Filed: 1997-06-06
Abstract: A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles dispersed in an aqueous solution of a binding agent of locust bean, gum, gelatine, vegetable hydrocolloids and/or animal protein.
Patent IL-130858-A0 (IL)
Title: Cyanoacrylate compositions comprising an antimicrobial agent
IPC: A61L17/00
Filed: 1997-10-09
Abstract: Disclosed are cyanoacrylate compositions comprising a compatible antimicrobial agent and, in particular, a compatible iodine containing antimicrobial agent. These compositions provide for in situ formation of an antimicrobial polymeric cyanoacrylate film on mammalian skin.
Patent IL-131956-A0 (IL)
Title: Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
IPC: A61P9/06
Filed: 1998-03-19
Abstract: PCT No. PCT/IT98/00060 Sec. 371 Date Sep. 24, 1999 Sec. 102(e) Date Sep. 24, 1999 PCT Filed Mar. 19, 1998 PCT Pub. No. WO98/43945 PCT Pub. Date Oct. 8, 1998Stable and non hygroscopic salts of L-carnitine or lower alkanoyl-L-carnitine with 2-aminoethanesulfonic acid are disclosed suitable for preparing solid compositions useful as dietary/nutritional supplements for human use and as fodder supplement for veterinary purposes.
Patent IL-139160-A0 (IL)
Title: Frangible metal bullets, ammunition and method of making such articles
IPC: F42B5/00
Filed: 1999-04-22
Abstract: A frangible metal bullet, a method for making it, and ammunition made therefrom. The frangible metal bullet is formed from a mixture of metal particles and metal or metalloid binder forming material which is compacted into the desired shape, heated to a temperature above that needed to form at least one intermetallic compound but below the temperature of joining of the metal particles by sintering and below the temperature of formation of substantial amounts of a ductile alloy of the metal of the particles and the metal or metalloid binder forming material and then cooled. Such bullets have sufficient strength to maintain their integrity during firing but disintegrate into powder on impact and can be formulated to be lead-free.
Patent IL-146639-A0 (IL)
Title: Printed media parallel binder
IPC: H04N7/173
Filed: 2000-05-24
Abstract: A system is provided having a sensing device for sensing coded data printed on a print media surface which is installed with a secret key and a first identifier which uniquely identifies the sensing device, a printer installed with a second identifier which uniquely identifies the printer, and a server installed with the first and second identifiers. The printer obtains the first identifier from the sensing device and communicates the first and second identifiers to the server. The server determines from the received first and second identifiers whether the sensing device should be registered with the printer and if so, authenticates the sensing device by verifying an encryption from the sensing device, using the secret key, of a challenge message. Upon successful authentication, the sensing device is registered in the server so as to be associated with the printer.
Patent IL-147618-A0 (IL)
Title: Method for treating chronic pain using mek inhibitors
IPC: C07C311/48
Filed: 2000-07-05
Abstract: The invention features a method for treating chronic pain using a compound selected from formulae (I), (II)A, (I)B and (I)C as shown in the claims.
Patent IL-147719-A0 (IL)
Title: Method and apparatus for concurrently processing multiple calls in a spread spectrum communications system
IPC: H04W28/18
Filed: 2000-08-11
Abstract: The call processing state machines defined by the CDMA standards (e.g., IS-95 and IS-2000) are modified to include a "traffic channel" substate indicative of the mobile station processing at least one active call. Call control (CC) state machines of various types are also provided to control the processing of the calls. To process one or more calls concurrently, a CC state machine is instantiated upon receiving an indication to process a particular call. The instantiated CC state machine is identified with, and used to control the processing of, the particular call. Upon receiving an indication to process an additional call, another CC state machine can be instantiated for the additional call. Each call to be processed can also be associated with a particular a service option connection, which includes information indicative of a set of parameters (e.g., the physical channels) to be used for data transmission.
Patent IL-162827-A0 (IL)
Title: A process for producing phenserine and its analog
IPC: C07D487/04
Filed: 2002-12-11
Abstract: A process for preparing phenserine compounds which are known acetylcholinesterase inhibitors from physostigmine compounds by hydrolysis to form an eseroline compound which is then condensed with an isocyanate.
Patent IL-190742-A0 (IL)
Title: Guaifenesin sustained release formulation and tablets
IPC: A61K47/20
Filed: 2008-04-09
Abstract: The invention relates to a modified release pharmaceutical product having two portions, wherein a first portion comprises a first quantity of guaifenesin and a first pharmaceutical additive in an immediate release formulation, wherein the first quantity of guaifenesin becomes fully bioavailable in the subject's stomach, and a second portion comprises a second quantity of guaifenesin and a second pharmaceutical additive in a sustained release formulation, wherein the ratio of said first quantity to said second quantity provides a C max  in a human subject equivalent to the C max  obtained when the first of three doses of a standard immediate release formulation having one third of a total amount of guaifenesin in the modified release product is dosed every four hours over a 12 hour period, wherein said product also provides therapeutically effective bioavailability for at least twelve hours after a single dose in a human subject according to serum analysis, and wherein the total amount of guaifenesin in the modified release product is from 600 mg to 1200 mg.
Patent IL-194806-A0 (IL)
Title: Anti-viral pyrimidine nucleoside derivatives
Filed: 2008-10-22
Abstract: A compound for use in the treatment or prophylaxis of viral infections such, for example as chicken pox or shingles caused by the Varicella Zoster virus, said compound having the general formula (II): wherein X is O, S, NH or CH2, Y is O, S or NH, Z is O, S or CH2, R1 is C1-6 alkyl, preferably n-alkyl, e.g., n-pentyl or n-hexyl, and one of R2 and R3 is OH, and the other of R3 and R2 is a neutral, non-polar amino acid moiety, or a pharmaceutically acceptable salt or hydrate thereof. Said neutral, non-polar amino acid moiety R2 or R3 may be (IV): in which R4, R5, R6 and R7 are each independently H or C1-2 alkyl. In preferred embodiments, one of R2 or R3 is valine, leucine, isoleucine or alanine, particularly valine.
Patent IL-226185-A0 (IL)
Title: Inhaler
IPC: A61M15/00
Filed: 2006-04-05
Abstract: An inhaler (1) comprising a housing (2) to receive a blister (6a) having a puncturable lid (6c) and containing a dose of medicament for inhalation by a user is disclosed. It comprises a mouthpiece (5) through which a dose of medicament is inhaled by a user, a blister piercing member (7) comprising at least two discrete piercing heads (9) operable to pierce a corresponding number of holes in said blister, an actuator (3) comprising an arm pivotally mounted to the housing at one end, and an opening formed in the vicinity of each piercing head. At least one of said openings forms an airflow inlet into said blister and, at least one other of the openings forming an airflow outlet from said blister. The mouthpiece includes a primary chamber (31) having an outside air inlet (34) in communication, via the primary chamber, with the or each airflow inlet opening and, a secondary chamber (32) in communication with the or each airflow outlet opening. When a user inhales through the mouthpiece, air is drawn through the or each airflow inlet opening into the blister via the outside air inlet and the primary chamber to entrain the dose in the airflow, said entrained dose passing through the or each airflow outlet opening into the secondary chamber of the mouthpiece from where it is carried into the user's airway.
Patent RO-126598-A0 (RO)
Title: Blast-heating apparatus and process for reducing heat losses for central stations with forced draught
Inventor: BOGDAN DOMINIC
IPC: F28D1/00
Filed: 2011-04-21
Abstract: The invention relates to a blast heating apparatus and to a process for reducing the heat losses for the thermal stations with forced draft, meant to heat the inlet air, particularly the air in excess, said apparatus being mounted to the exhaust gases outlet shaft. The blast-heating apparatus claimed by the invention comprises two metal tubes (1 and 2), arranged concentrically which are mounted on the exhaust gases outlet shaft of the thermal stations, by means of some rubber sleeves (3, 4) and of a collar (5), and the inner tube for the exhaust gases outlet, made by extruding from an aluminium alloy and processed at the ends for providing the attachment, is provided on the whole length with more fins (10) arranged longitudinally inside, and also with more fins (9) arranged longitudinally outside. According to the invention, the process for reducing the losses wherethrough the inlet air is heated before the inlet into the combustion chamber of the plant by means of the roast gases by at least 10°C more than the temperature at the outer end wherefrom the inlet is carried out.
Patent RO-129148-A0 (RO)
Title: Foldable device for the maintenance of aircrafts
Inventor: DIMA DUMITRU-GABRIEL
IPC: A61G1/017
Filed: 2013-07-04
Abstract: The invention relates to a foldable device used in particular in assembling and maintenance operations, overhauls or repairs of a medium-sized or relatively small aircraft. According to the invention, the device comprises some lateral and central rods (5 and 6), respectively, which allow the synchronization of motion between the seat (1), with a foot rest (2), a backrest (3) and some springs (12) for facilitating the return to the sitting position and some double pivoting wheels (7).
Patent IE-910807-A1 (IE)
Title: Process for the preparation of superconducting phases based¹on bismuth, strontium, calcium, copper, and a stabilizing¹element
IPC: H01B13/00
Filed: 1991-03-11
Abstract: Process for the preparation of a superconductive product based on bismuth, strontium, calcium, copper and oxygen, comprising at least one stabilising element chosen from the group comprising lead, antimony and tin, and characterised in that it comprises the following stages: a - preparation of a solution containing the elements bismuth, strontium, calcium, copper and at least one stabilising element, b - drying the said solution, c - calcination of the dried product in air. A product exhibiting a single transition temperature is thus obtained in a single stage.
Patent LU-87184-A1 (LU)
Inventor: FRANKHAUSER PETER
IPC: A61K47/10
Filed: 1988-03-30
Abstract: The transdermal therapeutic system is used for the combined administration of oestrogens and gestagens. The therapeutic system consists of
 (1) a covering layer which is closed and impermeable to the constituents of the active agent formulation,
 (2) a reservoir containing essential constituents of the active agent formulation and, if desired, a membrane,
 (3) an adhesive layer and
 (4) a protective layer, which can be pulled off, on the adhesive layer. 
<??>The system contains an oestrogen derivative in combination with a synthetic gestagen and an agent which increases percutaneous absorption.
Patent MA-27139-A1 (MA)
Title: Anticorps au cd40.
Inventor: BEDIAN VAHE
IPC: C12N5/09
Filed: 2004-04-05
Abstract: Abstrait [0331] La présente invention concerne les anticorps et les parties antigène-liantes de tel anticorps qui lient spécifiquement à CD40, CD40 de préférence humain, et qui fonctionnent comme des agonistes de CD40. L'invention se relie également aux anticorps anti-CD40 humains et aux parties antigène-liantes de cela. L'invention se relie également aux anticorps qui sont les anticorps ou les parties de protéines de fusion chimériques,bispecifiques, dérivatisés, à chaîne seule. L'invention se relie également aux immunoglobulines à chaîne lourde et légère isolée dérivée des anticorps anti-CD40 humains et des molécules d'acide nucléique codant de telles immunoglobulines. La présente invention se relie également aux méthodes de la fabrication des anticorps anti-CD40 humains, compositions comportant ces anticorps et méthodes d'employer les anticorps et les compositions pour le diagnostic et le traitement. L'invention fournit également des méthodes de thérapie de gène en utilisant des molécules d'acide nucléique codant les molécules lourdes et/ou légères d'immunoglobuline qui comportent les anticorps anti-CD40 humains. L'invention se relie également aux animaux de tranférement génique (transgénique) comportant des molécules d'acide nucléique de la présente invention
Patent MA-28156-A1 (MA)
Title: Beta-lactames pour le traitement de troubles du systeme nerveux central
Inventor: ALVARO GIUSEPPE
IPC: C07D401/04
Filed: 2006-05-11
Abstract: Bêta-lactames pour le traitement de troubles du SNC La présente invention concerne des composés nouveaux de formule (I)  dans laquelle ¿ ---- représente une liaison simple ou une double liaison ; ¿ R représente un radical choisi entre des radicaux :  dans lesquels R1 représente un atome d'halogène, un groupe cyano, alkyle en C1 à C4, alkoxy en C1 à C4, trifluorométhyle ou trifluorométhoxy et p est égal à zéro ou un nombre entier de 1 à 3 ; - R2 représente un atome d'hydrogène ou un groupe alkyle en C1 à C4 ; - R3 représente un atome d'hydrogène, un groupe hydroxy ou alkyle en d à C4 ; - R4 représente un atome d'hydrogène ou bien R4, conjointement avec R3, représente un groupe =0 ou =CH2 ; - R5 représente un groupe phényle, un groupe naphtyle, un groupe hétérocyclique bicyclique condensé nona- à décagonal ou un groupe hétéroaryle penta- ou hexagonal, lesdits groupes étant facultativement substitués avec 1 à 3 groupes choisis indépendamment entre des groupes trifluorométhyle, alkyle en C1 à C4, hydroxy, cyano, alkoxy en Cx à C4, trifluoro-méthoxy, halogéno et S(O)q(alkyle en C1 à C4) ; - R6 et R7 représentent indépendamment un atome d'hydrogène, un groupe cyano ou alkyle en C1 à C4 ; - R8 représente un groupe (CH2)rR10 ; - R9 représente un atome d'hydrogène, un atome d'halogène, un groupe cycloalkyle en C3 à C7, hydroxy, nitro, cyano ou alkyle en C1 à C4 facultativement substitué avec un ou deux groupes choisis entre des groupes halogéno, cyano, hydroxy et alkoxy en C1 à C4 ; - R10 représente un atome d'hydrogène ou un groupe cycloalkyle en C3 à C7 ; - n est égal à 1 ou 2 ; - q est égal à 0, 1 ou 2 ; - r est égal à 0 ou un nombre entier de 1 à 4 ; ou un de leurs sels pharmaceutiquement acceptables ou bxen un de leurs produits de solvatation, un procédé pour leur préparation et leur utilisation dans le traitement d'affections à médiation par des tachykinines et/ou par inhibition sélective de la protéine transporteur de réabsorption de sérotonine.
Patent MA-38541-A1 (MA)
Title: Facteurs de transcription artificiels génétiquement modifiés pour pallier le piégeage endosomique
Inventor: FLAMMER JOSEF
IPC: C07K14/47
Filed: 2015-10-21
Abstract: L'invention concerne un facteur de transcription artificiel comprenant une protéine à doigt de zinc polydactyle ciblant spécifiquement un promoteur de gène, génétiquement modifié pour pallier le piégeage endosomique après transduction dans des cellules. Un tel facteur de transcription artificiel comprend une protéine à doigt de zinc polydactyle, condensée à un domaine de protéine d'inhibition ou d'activation, une séquence de localisation nucléaire, un domaine de transduction de protéine, et un site de reconnaissance de protéase spécifique à l'endosome. Ces facteurs de transcription artificiels transductibles sont particulièrement utiles pour le traitement de maladies provoquées ou modulées par des protéines réceptrices liées à la membrane, des protéines réceptrices nucléaires ou des produits de gènes haplo-insuffisants.
Patent UY-24569-A1 (UY)
Title: Antagonistas de receptor de benzoxazinona dopamina d4
Inventor: BELLIOTTI THOMAS R WISE LAWRENCE D
IPC: C07D265/36
Filed: 1997-05-28
Abstract: Esta invención se relaciona con compuestos que son antagonistas de receptores de dopamina D4, con métodos para tratar la psicosis y la esquizofrenia usando un compuesto que es un antagonista de receptores de dopamina D4 y con composiciones farmacológicamente aceptables que contienen un antagonista de receptor de dopamina D4.
Patent UY-24840-A1 (UY)
Title: Productos absorbentes que tienen medios conformadores
Inventor: ULMAN JOHN
IPC: A61F13/15
Filed: 1998-01-08
Abstract: PRODUCTO ABSORBENTE USADO POR UNA MUJER PARA LA HIGIENE FEMENINA,QUE COMPRENDE UNA CAPA PERMEABLE A LIQUIDOS QUE DA AL CUERPO,UNA CAPA IMPERMEABLE A LIQUIDOS Y HACIA LA PRENDA UNA ESTRUCTURA ABSORBENTE. El producto absorbente de esta invención comprende además por lo menos un medio conformador contenido dentro de la por lo menos regíon extrema; el medio conformador comprende una región no endurecida adyacente al extremo distante de la región central y adyasente a un elemento endurecido, estando localizado hacia adentro de los bordes transversales y longitudinales del elemento adsorbente. Las salientes u orejas ayudan a mantener la superficie de la región central de la toalla plana y abierta a lo largo del eje longitudinal de la toalla.